Arjun Agarwal, Senior Vice President, Finance, on July 13, 2026, sold 9,999 shares in Oruka Therapeutics (ORKA) for $846,180. Following the Form 4 filing with the SEC, Agarwal has control over a total of 15,312 common shares of the company, with 15,312 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/xslF345X05/form4.xml